Länkar
www.cancer.gov National Cancer Institute
www.cnn.com/HEALTH/9803/17/vitamin.e.prostate/
Robert (Bob) Leibowitz
http://www.prostatepointers.org/prostate/leibowitz/
Svenska patientföreningen för prostatacancer http://www.proliv.com/index.htm
Publicerade artiklar:
D'Amico A. et al.: Short post-treatment PSA doubling time a marker of mortality.: J Natl Cancer Inst 2003;95:1352-1353, 1376-1383
Bill-Axelson, Anna, et al.: Radikal prostatectomi minskar risken för död i prostatacancer. Läkartidningen, vol 100, Nr19, 2003, 1714-1716
Brown, Jean K. et al: New recommendations guide nutrition and exercise choices for cancer survivors. CA Cancer J Clin;53:268-291.
Bruner,Deborah Watkins et al.:Prostate cancer risk highest when brother has the disease.: Int J Cancer 2003;107.
Clark L.C., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957-1963, 1996
van der Cruijsen-Koeter, Ingrid W. et al: Prostate cancer screening interval of 4 years misses a few cancers. J Natl Cancer Inst 2003;95:1462-1466.
Heinonen OP, et al.. Prostate cancer and supplementation with alpha-tocopherol and beta-carotine: incidence and mortality in a controlled trial. J. Natl Cancer Inst 90:400-6, 1998.
Hsu, Ao-Lin et al. : The Cyclooxygenase-2 Inhibitor
Celecoxib Induces
Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of
Bcl-2*.: The journal of Biological Chemistry, Vol 275, No15, Issue of april 14, pp
11397-11403, 2000
Klippel,Karl Friedrich. Prostatakarzinom: psychoonkologische Aspekte. Deutsche Zeitschrift für Onkologie, 2002; 100-105
Koki, Alane T et al.: Celecoxib: A specific Cox-2 inhibitor with anticancer properties: Cancer control, 2002, Vol 9,N.2 supplement, 28-35
Koumenis, Constantinos et al.:Vitamin D enhances radiation's ability to kill prostate cancer cells. B J of Cancer, 2003
Leibowitz,Robert, Tucker,S.: Treatment of Localized Prostate Cancer With Intermittent Triple Androgen Blockade: Preliminary Results in 110 Consecutive Patients. The Oncologist, Vol 6, No.2, 177-182, April 2001
Leitzmann MF et al.: Zink supplement use and risk of prostate cancer. J Natl Cancer Inst 2003 Jul 2;95(13): 1004-7
Pruthi, Ray et al:Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review. The Journal of Urology. Vol.169,2352-2359, June 2003
Ross et al.:Biphosphanates reduce skeletal morbidity of metastatic cancer. British Medical Journal, 2003;327:469-472..
Song, Xueqin et al.: Cyclogenase-2, Player or spectator in Cyclooxygenase-2 Inhibitor-Induced Apoptosis in Prostate Cancer Cells.Journal of the national cancer institute, Vol94, No 8, april 17,2002
Hormonrefraktär prostatacancer:
Jimeno A, Carducci M: Atrasentan: targeting the endothelin
axis in prostate cancer.
Expert Opin Investig Drugs. Pages: 1631-40; Volume(Issue): 13 (12)
Dec 2004 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University,
Bunting-Blaustein Cancer Research Building, Room 1M89, 1650 Orleans Street, Baltimore, MD
21231-1000, USA.
Nelson JB: Endothelin receptor antagonists. World J Urol. Pages: ;
Volume(Issue): ()
15 Jan 2005 Department of Urology, University of Pittsburgh School of Medicine, 5200
Centre Ave, Suite 209, Pittsburgh, PA 15232, USA, nelsonjb@upmc.edu.
Ryan CW, et al.: Clin Cancer Res. Pages: 4406-11; Volume(Issue):
10 (13) Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients
with refractory malignancies.
1 Jul 2004 Section of Hematology/Oncology, Department of Medicine, Cancer Research Center,
and Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago,
Chicago, and Abbott Laboratories, Abbott Park, Illinois, USA. ryanc@ohsu.edu
Tannock IF, et al.: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.N Engl J Med. Pages: 1502-12; Volume(Issue): 351 (15)
7 Oct 2004 Department of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, ON, Canada. ian.tannock@uhn.on.ca
Doktorsavhandlingar
Jönsson Videsäter, Kerstin
Expression of multidrug resistance genes and proteins and
effect of selenite in anthracycline-resistant human tumor cell lines. ISBN:91-7349-889-0
Böcker i ämnet:
Ditt PSA är för högt-mitt möte med prostatacancer. Lars Göran Pärletun. 2003. Bokförlaget Vivamos. ISBN 91-631-3887-5
Prostatacancer - information för patienter och anhöriga. Per-Anders Abrahamsson. AstraZeneca Sverige 2003. ISBN 91-86327-61-5
Prostatacancer Råd, rön, möjligheter. Sten Nilsson & Lennart Levi. 2003 Radiumhemmets Forskningsfonder. ISBN 91-631-3567-1
Själens läkande kraft. Bill Moyers. Svenska Dagbladets Förlags AB 1994. ISBN 91-7738-362-1
A revolutionary approach to prostate cancer. Dr Aubrey Pilgrim. Sterling House Publisher. ISBN 1-56315-0867. 1998.
The herbal remedy for prostate cancer. James Lewis. Health Education Literary Publisher, ISBN 1-883257-02-6. 1999.
Kongressrapporter:
VII internationella kongressen i andrologi, Montreal, Kanada, 15-19 juni 2001
American Urological Association, Orlando, USA, 25-30 maj 2002